Abstract:Open scientific competitions have successfully driven biomedical advances but remain underutilized in aging research, where biological complexity and heterogeneity require methodological innovations. Here, we present the results from Phase I of the Biomarkers of Aging Challenge, an open competition designed to drive innovation in aging biomarker development and validation. The challenge leverages a unique DNA methylation dataset and aging outcomes from 500 individuals, aged 18 to 99. Participants are asked to develop novel models to predict chronological age, mortality, and multi-morbidity. Results from the chronological age prediction phase show important advances in biomarker accuracy and innovation compared to existing models. The winning models feature improved predictive power and employ advanced machine learning techniques, innovative data preprocessing, and the integration of biological knowledge. These approaches have led to the identification of novel age-associated methylation sites and patterns. This challenge establishes a paradigm for collaborative aging biomarker development, potentially accelerating the discovery of clinically relevant predictors of aging-related outcomes. This supports personalized medicine, clinical trial design, and the broader field of geroscience, paving the way for more targeted and effective longevity interventions.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the key limitations in the current development and validation of aging biomarkers. Specifically, by presenting the results of the first phase of the "Biomarkers of Aging Challenge", the paper aims to: 1. **Improve the accuracy of aging biomarkers**: Existing biomarkers have limitations in predicting an individual's physiological age and age - related health conditions. The paper shows that through the form of an open competition, contestants can develop prediction models that are more accurate than existing models. 2. **Promote methodological innovation**: The biological complexity and heterogeneity in aging research require methodological innovation. The competition encourages contestants to use advanced machine - learning techniques, innovative data pre - processing methods, and integrate biological knowledge to develop new models. 3. **Accelerate the discovery of clinically relevant predictors**: Through the form of a competition, researchers can quickly iterate and optimize models, thereby accelerating the discovery of clinically significant aging biomarkers. This is helpful for personalized medicine, clinical trial design, and broader aging science research, and ultimately promotes the development of more precise and effective longevity interventions. 4. **Establish a cooperation paradigm**: The competition provides a standardized dataset and evaluation framework, which promotes interdisciplinary cooperation and enables experts from different fields to jointly promote the research of aging biomarkers. In summary, the core objective of this paper is to promote the development and validation of aging biomarkers through an open competition platform, with the expectation of making significant progress in terms of accuracy, innovation, and clinical applications.

An Open Competition for Biomarkers of Aging